Add Company
Join Now

Cerevance Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

$91.5M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Cerevance's estimated annual revenue is currently $6.1M per year.(i)
  • Cerevance's estimated revenue per employee is $100,500
  • Cerevance's total funding is $91.5M.

Employee Data

  • Cerevance has 61 Employees.(i)
  • Cerevance grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M12-52%N/AN/A
#4
$25.7M12839%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M51-14%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M2493%N/AN/A
Add Company

Cerevance

keywords:N/A

$91.5M

Total Funding

61

Number of Employees

$6.1M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cerevance's People

NameTitleEmail/Phone
1
ControllerReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Research ScientistReveal Email/Phone
4
Senior Director, Head DMPK, CerevanceReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
SVP, Clinical and Translational MedicineReveal Email/Phone
7
Senior ScientistReveal Email/Phone
8
Principal ScientistReveal Email/Phone
9
VP Drug DiscoveryReveal Email/Phone
10
Director, NeuroscienceReveal Email/Phone

Cerevance News

2022-04-17 - Leadership transition at Cerevance

Brad Margus will transition from CEO of Cerevance to executive chairman of the board at the end of April. Cerevance was launched by Japan's...

2022-04-13 - Cerevance Announces Leadership Transition to Implement ...

BOSTON, April 19, 2022 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central...

2022-03-22 - With Positive Phase II Results, Cerevance Proves Concept in ...

Cerevance is focused on brain and central nervous system (CNS) disease treatments. Most of the company's drug discovery comes from the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.4M613%$62.6M
#2
$8.2M610%N/A
#3
$11.5M61-6%N/A
#4
$15.9M612%N/A
#5
$11.7M61-54%$277.7M

Cerevance Executives


NameTitle
Brad MargusCEO
Mark CarltonChief Scientific Officer
Nathaniel HeintzChief Scientific Advisor
Robert MiddlebrookChief Financial Officer
Carrie CookChief Business Officer
Rob MiddlebrookChief Financial Officer
Mark CarltonCSO
David MargolinSenior Vice President, Clinical and Translational Medicine
Lee DawsonVP of Neuroscience
Roland BurliVP Drug Discovery
Naidong YeVP and Head of CMC
David MargolinSenior VP, Clinical and Translational Medicine
Naidong YeVP, Head of CMC
Naidong YeVice President/Head of CMC
Lee DawsonVP Neuroscience
Johnna SimōesVice President, Corporate Development